Manuscripts
Showing 1554 manuscripts.
Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs
Citation
Richard A. Koup, John L. Sullivan, Peter H. Levine, Doreen Barbara Brettler, Anna Mahr, Gail Mazzara, Sara J. McKenzie, Dennis Panicali. Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. Blood. 1989. 73: 1909-14.Year
1989
Journal
Blood
Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee
Citation
Susan E. Krown, Craig E. Metroka, James C. Wernz. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee. Journal of Clinical Oncology. 1989. 7: 1201-7.Year
1989
Journal
Journal of Clinical Oncology
Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin
Citation
Gad Lavie, Fred T. Valentine, Brandi Levin, Yehuda Mazur, Gloria Gallo, David Lavie, David B. Weiner, Daniel Meruelo. Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin. Proceedings of the National Academy of Sciences of the United States of America. 1989. 86: 5963-7.Year
1989
Journal
Proceedings of the National Academy of Sciences of the United States of America
Dextran sulfate is poorly absorbed after oral administration
Citation
Kevin Lorentsen, Craig Hendrix, Jerry Collins, David Kornhauser, Brent Gray Petty, Paymong W. Klecker, Charles Flexner, Robert H. Eckel, Paul S. Lietman. Dextran sulfate is poorly absorbed after oral administration. Annals of Internal Medicine. 1989. 111: 561-6.Year
1989
Journal
Annals of Internal Medicine
Clinical role of granulocyte-macrophage colony-stimulating factor
Citation
Ronald T. Mitsuyasu, David W. Golde. Clinical role of granulocyte-macrophage colony-stimulating factor. Hematology/Oncology Clinics of North America. 1989. 3: 411-25.Year
1989
Journal
Hematology/Oncology Clinics of North America
Human immunodeficiency virus infection. Clinical diagnosis
Citation
William G. Powderly. Human immunodeficiency virus infection. Clinical diagnosis. Missouri Medicine. 1989. 86: 625-7.Year
1989
Journal
Missouri Medicine
Generation and administration of aerosols for medical and physiological research studies
Citation
Gerald C. Smaldone. Generation and administration of aerosols for medical and physiological research studies. Journal of Aerosol Medicine. 1989. 2: 81-7.Year
1989
Journal
Journal of Aerosol Medicine
Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine
Citation
Margo Smith, E. L. Brian, Joseph S. Pagano. Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine. Antimicrobial Agents and Chemotherapy. 1989. 33: 1482-6.Year
1989
Journal
Antimicrobial Agents and Chemotherapy
Oxidative burst capability of human monocyte subsets defined by high and low HLA-DR expression
Citation
Greg Spear, Robert A. June, Alan Landay. Oxidative burst capability of human monocyte subsets defined by high and low HLA-DR expression. Immunological Investigations. 1989. 18: 993-1005.Year
1989
Journal
Immunological Investigations
Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone
Citation
Stephen A. Spector, D. Ripley, Karen Hsia. Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone. Antimicrobial Agents and Chemotherapy. 1989. 33: 920-3.Year
1989
Journal
Antimicrobial Agents and Chemotherapy